Tohoku

J. exp.

Med.,

1975,

116, 101-102

Short

Viral

Hepatitis

B and

Aplastic

Snozo NAKAMURA, TAKASHI and YASUSHI SATO*

Report

Anemia

SATO,

TOSHIYUKI

MAEDA*

The First Departmentof Internal Medicine, Tohoku University Schoolof Medicine,Sendai, and HikarigaokaSpellmanHospital,* Sendai

NAKAMURA, and

T.,

Aplastic

SATO,

Anemia.

many

cases

nature

of

of

T.,

Tohoku

hepatitis is

not

anemia aplastic

T.

and

Med.,

with

fully

hepatitis-B-antigen-positive

antigen;

exp.

associated

hepatitis

aplastic

MAEDA,

J.

aplastic

A

case

is presented.?

has

acute

viral

hepatitis

Y.

Viral

(1),

There of

viral

116 anemia

understood.

case.

SATO,

1975,

Hepatitis

101-102 •\

have

been

been

so

described, far

no

hepatitis

B;

B

Although

B

hepatitis

the

report

of

developing

B;

hepatitis

B

anemia

Since the association of hepatitis and aplastic anemia was first described by Lorenz and Quaiser (1955), approximately 100 cases of this association have been reported (Camitta et al. 1974). Although some of them belong to the chloramphenicol-hepatitis-aplastic anemia syndrome (Hodgkinson 1973), most of them are believed to have had acute viral hepatitis (Ajlouni and Doeblin 1974; Camitta et al. 1974). In spite of recent advances in detecting hepatitis B surface antigen (HBSAg), however, no HBS-Ag-positive case has been reported. In this paper a case of acute viral hepatitis B developing aplastic anemia is Dresented. A

71-year-old

1974.

One

May

17.

history

He of

physical

was

serum

zinc

phils

65%,

Bone

marrow

anabolic and

consistent

aplastic

lymphocytes

29%,

with

S.G.O.T.

and

weeks

S.G.P.T.

almost

after

to rose

the

for publication,

more

rest,

returned

increased

Hemoglobin

Received

with

Three

albumin

remained

controls,

treated

and

to same.

March

was

jaundice

to

2

normal

g/100ml

Thrombocytes

24, 1975. 101

7.0%, ƒÀ-

7.9

g/100ml,

thrombocytes

very

low

given

blood

red

2,22O/ƒÊ1

and

rate

(neutro 102,000/ƒÊ1.

myeloid

and

months

and ƒÁ-globulin

12.4

Total

of

erythroid

incorporation

236•~103dpm).

subsequently

admission

60.3%

2%),

had

than

test

units.

immunodiffusion.

count

megakaryocytes,

lymphocytes

(5•~103dpm; was

monocytes

sub

alkaline

turbidity

radial

cell

no

and

units,

515

hemoglobin blood

on

admission,

gingiva, 449

thymol

by

April,

was

2.3%, ƒ¿2-globulin

white

decreased

nose,

72,

positive

anemia;

0.5%,

Phytohemagglutinin-stimulated

patient

was

On

dehydrogenase

38.3%, ƒ¿l-globulin

with

hypocellular,

lactic

of admitted

There

S.G.P.T.

index

and

HBSAg

reticulocytes

4%,

was

admission. count

was

eosinophils

steroid.

gradually;

albumin 46.0%.

2,29O,000/ƒÊ1,

3H-thymidine The

g/100ml,

and ƒÁ-globulin

count

elements. of

8.8

units,

the

units,

prothrombin

48

middle was

admission.

from 840

the he

transfusion.

the

bleeding

in and

blood before

S.G.O.T.

units, test

fatigue

appeared,

drugs and

50,

noticed

received

other

was

he

bleeding not

jaundice

turbidity

were

picture

cell

had or

index

until

nasal

and

King-Armstrong

6.4%, blood

health and

revealed

sulphate

proteins

blood

good

abstainer,

Icterus

13.4

globulin

in

jaundice

chloramphenicol

tissue.

units,

The

an

taking

phosphatase

was

later

examination

cutaneous

11.7

male

month

later.

Serum

decreased after

transfusion

HBS-antigenemia

to

6

months,

increased

to

22.0% but

124,000/ƒÊl,

and

an

disappeared, globulin 6

improved months

white

after

blood and

bleeding

cell

102 stopped. slightly

The sternal hvpocellular.

marrow

showed

S. Nakamura

et al.

increases

in erythroid

and myeloid

cells, but remained

Although many cases of hepatitis developing aplastic anemia have been so far reported, the nature of hepatitis is not fully understood. The chloramphenicol-hepatitisaplastic anemia syndrome was proposed rather than viral hepatitis (Hodgkinson 1973). When viral hepatitis was considered, acute viral hepatitis A was suggested since HBSAg was negative in the patients tested (Ajlouni and Doeblin 1974). However, HBSAg was so far examined in only a small number of reported cases (Toda 1973; Ajlouni and Doeblin 1974; Camitta et al. 1974). The anemia.

present case is the first proved This case shows that patients

case of viral hepatitis B associated with with viral hepatitis can develop aplastic

and that the disease of at least some patients belongs to viral hepatitis HBS-antigenemia in hepatitis associated with aplastic anemia remains because of a small number of cases examined. Recently associations B with aplastic

glomerulonephritis and periarteritis nodosa are pointed out. anemia is also occasionally associated with viral hepatitis B.

aplastic anemia,

B. Incidence of to be determined of viral hepatitis

Now

it is clear

that

References

1)

Ajlouni, K. & Doeblin, T.D. (1974) The syndrome of hepatitis and aplastic anemia. Brit. J. Haematol., 27, 345-355. 2) Camitta, B.M., Nathan, D.G., Forman, E.N., Parkman, R., Rappeport, J.M. & Orellana, T.D. (1974) Posthepatitic severe aplastic anemia; An indication for early bone marrow transplantation. Blood, 43, 473-483. 3) Hodgkinson, R. (1973) The chloramphenicol-hepatitis-aplastic anaemia syndrome. Med. J. Austral., 1, 939-940. 4) Lorenz, E. & Quaiser, K. (1955) Panmyelopathie nach Hepatitis epidemica. Wien. med. Wochensch., 105, 19-22. 5) Toda, K. (1973) A case of aplastic anemia following infectious hepatitis . Nihon Shonika Gakkai Zasshi (Jap.), 77, 220.

Viral hepatitis B and aplastic anemia.

Although many cases of hepatitis associated with aplastic anemia have been described, the nature of hepatitis is not fully understood. There has been ...
124KB Sizes 0 Downloads 0 Views